Tcheng, J.E.

patient trial stroke tranilast abciximab placebo group restenosi study treatment heparin angioplasty angiographic difference result follow-up vessel randomized epilog nonhemorrhagic stroke circulation hemorrhagic infarction table investigator analysis epistent stent placebo group hemorrhagic stroke comparison frequency balloon angioplasty angiographic restenosis nonhemorrhagic intervention laboratory month epic trial lesion value low-dose population target intracranial point platelet /iiia disease effect stenosi abciximab bolus outcome treatment groups infusion efficacy 3 months hospital thrombolytic therapy event efficacy end point artery therapy university association erasmus mc regimen percutaneou figure complication stroke rates simoon receptor / hemorrhagic stroke standard-dose reduction angiography 4 trials epic rotterdam low-dose heparin regimen